Papers

Cardioprotective effect of hormone replacement therapy in postmenopausal women: is the evidence biased?

Department of Clinical Epidemiology, Leiden University Hospital, PO Box 9600, 2300 RC Leiden, Netherlands Correspondence and requests for reprints to: Dr Westendorp.

Abstract

Objective : To quantify the effect of selection of relatively healthy women in studies reporting reduced relative risk for cardiovascular disease in postmenopausal women taking hormone replacement therapy. Design - Review of the follow up studies reported in three recent meta- analyses to determine the effect of oestrogen therapy on both total cancer and cardiovascular disease. The same standard statistical methods as in the original analyses were used.
Main outcome measures : Relative risks of total cancer and cardiovascular disease.
Results : In most of the follow up studies the relative risk for total cancer was below 1. The studies that showed the largest reduction in cardiovascular disease also showed the largest reduction in cancer, indicating a healthy cohort effect. Although heterogeneity within the studies prevented pooling, the best estimate for the protective effect on total cancer was a relative risk of 0.83 among women taking oestrogen (95% confidence interval 0.71 to 0.96), while in the same studies the relative risk for cardiovascular disease was 0.57 (0.50 to 0.64).
Conclusions : Unintended selection of relatively healthy women for oestrogen therapy may have influenced the reported beneficial effect of oestrogen therapy on cardiovascular disease. It is unclear how much of the cardioprotection is due to this selection. Universal preventive hormonal replacement therapy for postmenopausal women is unwarranted at present.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    StumbleUpon    Technorati    What's this?

Relevant Article

Cardioprotective effect of hormone replacement therapy Is not due to a selection bias

M Stampfer, F Grodstein, D Spiers, W F M Posthuma, R G J Westendorp, and J P Vandenbroucke
BMJ 1994 309: 808-809. [Extract] [Full Text]

This article has been cited by other articles:

• Krieger, N. (2008). Hormone therapy and the rise and perhaps fall of US breast cancer incidence rates: critical reflections. Int J Epidemiol 37: 627-637 [Abstract] [Full text]  
• Vercambre, M.-N., Fournier, A., Boutron-Ruault, M.-C., Clavel-Chapelon, F., Ringa, V., Berr, C. (2007). Differential Dietary Nutrient Intake according to Hormone Replacement Therapy Use: An Underestimated Confounding Factor in Epidemiologic Studies?. Am J Epidemiol 166: 1451-1460 [Abstract] [Full text]  
• Krieger, N., Lowy, I., Aronowitz, R., Bigby, J., Dickersin, K., Garner, E., Gaudilliere, J.-P., Hinestrosa, C., Hubbard, R., Johnson, P. A, Missmer, S. A, Norsigian, J., Pearson, C., Rosenberg, C. E, Rosenberg, L., Rosenkrantz, B. G, Seaman, B., Sonnenschein, C., Soto, A. M, Thornton, J., Weisz, G. (2005). Hormone replacement therapy, cancer, controversies, and women's health: historical, epidemiological, biological, clinical, and advocacy perspectives. J. Epidemiol. Community Health 59: 740-748 [Abstract] [Full text]  
• Ades, P. A., Toth, M. J. (2005). Accelerated Decline of Aerobic Fitness With Healthy Aging: What Is the Good News?. Circulation 112: 624-626 [Full text]  
• Chilvers, C. E.D., Knibb, R. C., Armstrong, S. J., Woods, K. L., Logan, R. F.A. (2003). Post menopausal hormone replacement therapy and risk of acute myocardial infarction -- a case control study of women in the East Midlands, UK. Eur Heart J 24: 2197-2205 [Abstract] [Full text]  
• Col, N. F., Pauker, S. G. (2003). The Discrepancy between Observational Studies and Randomized Trials of Menopausal Hormone Therapy: Did Expectations Shape Experience?. ANN INTERN MED 139: 923-929 [Abstract] [Full text]  
• Barrett-Connor, E. (2003). An Epidemiologist Looks at Hormones and Heart Disease in Women. J. Clin. Endocrinol. Metab. 88: 4031-4042 [Full text]  
• Lambert, L J, Straton, J A Y, Knuiman, M W, Bartholomew, H C (2003). Health status of users of hormone replacement therapy by hysterectomy status in Western Australia. J. Epidemiol. Community Health 57: 294-300 [Abstract] [Full text]  
• Rosendaal, F.R., Helmerhorst, F.M., Vandenbroucke, J.P. (2002). Female Hormones and Thrombosis. Arterioscler. Thromb. Vasc. Bio. 22: 201-210 [Abstract] [Full text]  
• Hedblad, B., Merlo, J., Manjer, J., Engstrom, G., Berglund, G., Janzon, L. (2002). Incidence of cardiovascular disease, cancer and death in postmenopausal women affirming use of hormone replacement therapy. Scand J Public Health 30: 12-19 [Abstract]  
• Angerer, P., Stork, S., Kothny, W., Schmitt, P., von Schacky, C. (2001). Effect of Oral Postmenopausal Hormone Replacement on Progression of Atherosclerosis : A Randomized, Controlled Trial. Arterioscler. Thromb. Vasc. Bio. 21: 262-268 [Abstract] [Full text]  
• Rodriguez, C., Calle, E. E., Patel, A. V., Tatham, L. M., Jacobs, E. J., Thun, M. J. (2001). Effect of Body Mass on the Association between Estrogen Replacement Therapy and Mortality among Elderly US Women. Am J Epidemiol 153: 145-152 [Abstract] [Full text]  
• Varas-Lorenzo, C., Garcia-Rodriguez, L. A., Perez-Gutthann, S., Duque-Oliart, A. (2000). Hormone Replacement Therapy and Incidence of Acute Myocardial Infarction : A Population-Based Nested Case-Control Study. Circulation 101: 2572-2578 [Abstract] [Full text]  
• McNagny, S. E. (1999). Prescribing Hormone Replacement Therapy for Menopausal Symptoms. ANN INTERN MED 131: 605-616 [Abstract] [Full text]  
• Rossouw, J. E. (1999). Does Estrogen Have a Role in the Prevention of Cardiovascular Disease?. J. Clin. Endocrinol. Metab. 84: 1806-1810 [Full text]  
• Lewis, M. A., MacRae, K. D., Kuhl-Habich1, D., Bruppacher, R., Heinemann, L. A.J., Spitzer, W. O. (1999). The differential risk of oral contraceptives: the impact of full exposure history. Hum Reprod 14: 1493-1499 [Abstract] [Full text]  
• Barrett-Connor, E. (1998). Fortnightly review: Hormone replacement therapy. BMJ 317: 457-461 [Full text]  
• Rifkind, B. M., Rossouw, J. E. (1998). Of Designer Drugs, Magic Bullets, and Gold Standards. JAMA 279: 1483-1485 [Full text]  
• Yaffe, K., Sawaya, G., Lieberburg, I., Grady, D. (1998). Estrogen Therapy in Postmenopausal Women: Effects on Cognitive Function and Dementia. JAMA 279: 688-695 [Abstract] [Full text]  
• Skafar, D. F., Xu, R., Morales, J., Ram, J., Sowers, J. R. (1997). Female Sex Hormones and Cardiovascular Disease in Women. J. Clin. Endocrinol. Metab. 82: 3913-3918 [Abstract] [Full text]  
• Elhage, R., Arnal, J.-F., Pieraggi, M.-T., Duverger, N., Fievet, C., Faye, J.-C., Bayard, F. (1997). 17ß-Estradiol Prevents Fatty Streak Formation in Apolipoprotein E–Deficient Mice. Arterioscler. Thromb. Vasc. Bio. 17: 2679-2684 [Abstract] [Full text]  
• Cauley, J. A., Seeley, D. G., Browner, W. S., Ensrud, K., Kuller, L. H., Lipschutz, R. C., Hulley, S. B. (1997). Estrogen Replacement Therapy and Mortality Among Older Women: The Study of Osteoporotic Fractures. Arch Intern Med 157: 2181-2187 [Abstract]  
• Spector, T D, Nandra, D, Hart, D J, Doyle, D V (1997). Is hormone replacement therapy protective for hand and knee osteoarthritis in women?: The Chingford study. Ann Rheum Dis 56: 432-434 [Abstract] [Full text]  
• Grodstein, F., Stampfer, M. J., Colditz, G. A., Willett, W. C., Manson, J. E., Joffe, M., Rosner, B., Fuchs, C., Hankinson, S. E., Hunter, D. J., Hennekens, C. H., Speizer, F. E. (1997). Postmenopausal Hormone Therapy and Mortality. NEJM 336: 1769-1776 [Abstract] [Full text]  
• Col, N. F., Eckman, M. H., Karas, R. H., Pauker, S. G., Goldberg, R. J., Ross, E. M., Orr, R. K., Wong, J. B. (1997). Patient-Specific Decisions About Hormone Replacement Therapy in Postmenopausal Women. JAMA 277: 1140-1147 [Abstract]  
• Anderson, H. V. (1996). Estrogen Therapy, Atherosclerosis, and Clinical Cardiovascular Events. Circulation 94: 1809-1811 [Full text]  
• Margolis, K. L., Ensrud, K., Maldonado, M., Charney, P., Clayton, T., Rich-Edwards, J., Manson, J., Hennekens, C., Buring, J. (1995). The Prevention of Coronary Heart Disease in Women. NEJM 333: 1570-1572 [Full text]